April 3, 2025, Bengaluru, India: Xpheno Targets ₹500 Crore Revenue Milestone in its 9th Year of Operations: 80% Specialist Hiring, and Global Expansion Bengaluru, India, 3rd April 2025: Xpheno has announced its meticulous expansion, and specialization plans over the next two years as it prepares for its IPO, strategically positioning itself as the leading specialist […]
Xpheno Onboards New CEO, to Hit ₹500 Cr Revenue Goal Read More »
March 26, 2025: Hyderabad saw an unforgettable musical event as the Oscar-winning composer MM Keeravani (MMK) took the stage after 20 years for his highly anticipated “Naa Tour MMK” concert, presented in collaboration with Hyderabad Talkies. The 10,000-capacity indoor stadium was packed, and the energy was electric. MMK stirred the audience through a musical experience
MM Keeravani Enthralls Hyderabad with a Symphony of Sound and Story Read More »
Ink MoU to test and experiment Hylenr’s Low-Energy Nuclear Reaction (LENR) technology for space-based compute infrastructure Hyderabad, India, 26th March 2025 – Hyderabad based startup Hylenr Technologies, a leader in clean energy innovation, has signed a Memorandum of Understanding (MoU) with TakeMe2Space, a pioneering space-tech company, to develop and test LENR powered compute modules in space. TakeMe2Space is actively exploring
Hylenr to Test Clean Energy Tech in Space with TakeMe2Space Read More »
Hyderabad, India, March 13, 2025 — Syneriq Global has officially launched its state-of-the-art AI-First Global Capability Centre (GCC) in Hyderabad, reinforcing its commitment to shaping the future of digital transformation. With a significant investment of ₹50 crores, the new 40,000 square foot facility will drive the company’s mission to lead innovation and advance product engineering
Syneriq Global’s New GCC Vision Strengthens Telangana’s AI City Ambition Read More »
Hyderabad, February 28, 2025 –Fanatics, a leading global digital sports platform with 22,000 employees across more than 80 locations, has announced strengthening of its leadership, increasing in technical hiring, and expanding its footprint within India.Fanatics continues to grow and scale its business with technology, data, and the application of AI to drive the company’s success.
Fanatics Expands in India: New VP, Larger Office, 500+ Team by 2026 Read More »
Bengaluru, February 18, 2025: SKEGEN Asset Management LLP, a PE fund manager has signed an MoU with iDEX India (Innovation for Defence Excellence). SKEGEN has earmarked ~ ₹500 crores to back the defence sector in India. As part of this commitment, it has invested/committed ₹360 Crores in 2 iDEX winners, namely, Sagar Defence Engineering Pvt
SKEGEN Commits ₹360 Cr for Two iDEX Winners Read More »
Mallur, Karnataka, February 11 2025 — In a groundbreaking development for the animal health sector, Biovet, a leading innovator in animal vaccines and a part of the Bharat Biotech Group, has announced that its world-first Differentiating Infected from Vaccinated Animals (DIVA) marker vaccine for Lumpy Skin Disease (LSD) has been granted approval by the Central
CDSCO Approves Biovet’s Safe, Effective DIVA LSD Vaccine for Dairy Cattle Read More »
Hyderabad, India, January 15, 2025: AM Green, a leader in green hydrogen and ammonia production, has partnered with DP World, a global logistics leader, to create a sustainable supply chain for green fuels and chemicals. This collaboration will significantly enhance global decarbonisation efforts by enabling seamless exports to key consumption markets. Under the Memorandum of
AM Green, DP World Pact to Export 2MPTA Green Fuels Read More »
September 20, 2024: RWE Supply & Trading has signed a Memorandum of Understanding (MoU) with AM Green Ammonia B.V. (AMG) for the long-term supply of green ammonia from its plants based in India. It outlines the supply of up to 250,000 tonnes of green ammonia per year. The ammonia will be sourced from AMG’s production
AM Green Strikes 250,000-Tonne Green Ammonia Supply Deal with RWE Read More »
August 28, 2024: Bharat Biotech International Limited (BBIL) announced the launch of HILLCHOL® (BBV131), a novel single-strain Oral Cholera Vaccine (OCV). The OCV was developed by Bharat Biotech under license from Hilleman Laboratories (funded by Merck, USA and Wellcome Trust, UK), to combat cholera, a significant advancement in global health. Currently, only one manufacturer supplies
New Oral Cholera Vaccine ‘HILLCHOL’ by Bharat Biotech Tackles Global Deficit Read More »
